Investigating how phosphorylation affects neuron channel activity related to epilepsy
Structural consequences of PKC-dependent phosphorylation of Kv7.2
This study is looking at how a special part of brain cells, called the Kv7.2 channel, changes when it gets a chemical tweak, and it hopes to find out how this affects signals in the brain, which could help people with epilepsy, especially those with certain genetic changes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arkansas at Fayetteville NIH-funded |
| Lab location | 1 site (Fayetteville, United States) |
| Project ID | NIH-11127098 on NIH RePORTER |
What this research studies
This research focuses on understanding the structural changes in a specific neuron channel, known as Kv7.2, which is crucial for regulating neuron excitability. The study aims to explore how phosphorylation, a chemical modification, influences the binding of important signaling molecules to this channel. By using advanced techniques like NMR, researchers will investigate the interactions between these molecules and the channel, which could lead to new insights into the mechanisms behind epilepsy. Patients with mutations in the Kv7.2 subunit may particularly benefit from the findings of this research.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with neonatal epilepsy linked to mutations in the Kv7.2 gene.
Not a fit: Patients without mutations in the Kv7.2 gene or those with other forms of epilepsy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating epilepsy caused by Kv7.2 mutations.
How similar studies have performed: Previous research has shown that understanding the molecular mechanisms of ion channels can lead to significant advancements in epilepsy treatment, indicating a promising avenue for this study.
Where this research is happening
Fayetteville, United States
- University of Arkansas at Fayetteville — Fayetteville, United States (Active)
Researchers
- Principal investigator: Archer, Crystal Rae — University of Arkansas at Fayetteville
- Study coordinator: Archer, Crystal Rae
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.